about
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for au...
Read More
2.56
-0.06
(-2.29%)
778.3K
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Savara Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..